BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 21929518)

  • 21. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
    Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
    Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PDE5 inhibitors for the management of temporary penile erectile dysfunction during treatment with assisted reproductive technology].
    Fei QJ; Pan CS; Hang XF
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):991-5. PubMed ID: 24341092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury.
    Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wilkins HJ; Wachs BH;
    Neurology; 2006 Jan; 66(2):210-6. PubMed ID: 16434656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vardenafil (levitra): new aspects of clinical efficacy].
    Gamidov SI; Iremashvili VV; Pavlovichev AA; Tazhetdinov OKh
    Urologiia; 2010; (6):44-7. PubMed ID: 21427994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
    Sakuma M; Shirato K
    Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
    Valiquette L; Montorsi F; Hellstrom WJ; Giuliano F; Homering M; Taylor T; Eardley I;
    Can J Urol; 2005 Jun; 12(3):2687-98; discussion 2699. PubMed ID: 16011816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study to evaluate the effects of vardenafil on sexual distress in men with obesity.
    Aversa A; Francomano D; Bruzziches R; Natali M; Guerra A; Latini M; Donini LM; Lenzi A
    Int J Impot Res; 2012; 24(3):122-5. PubMed ID: 22158147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction.
    Solak Y; Atalay H; Kan S; Kaynar M; Bodur S; Yeksan M; Turk S
    Int J Impot Res; 2011; 23(1):27-31. PubMed ID: 21209618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
    Porst H; Sharlip ID; Hatzichristou D; Rubio-Aurioles E; Gittelman M; Stancil BN; Smith PM; Wilkins HJ; Pommerville P;
    Eur Urol; 2006 Nov; 50(5):1086-94; discussion 1094-5. PubMed ID: 16820261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA; Isidori AM; Gravina GL; Aversa A; Balercia G; Bocchio M; Boscaro M; Carani C; Corona G; Fabbri A; Foresta C; Forti G; Francavilla S; Granata AR; Maggi M; Mansani R; Palego P; Spera G; Vetri M; Lenzi A;
    J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.